Kurdish expatriate physician Azad Najar unveiled a significant scientific breakthrough on Wednesday, announcing the development of a new model for an artificial heart. Dr. Najar confirmed that he has obtained the necessary licenses to begin human transplants early next year.
During a press conference held today in Erbil, Dr. Najar—originally from Akre and currently residing in Sweden—stated:
“The American Academy of Medical Sciences has granted official licensing for this innovation. It is scheduled to be implanted into patients’ chests next year for the first time globally.”
Implementation Timeline
The physician detailed that the initial surgeries will follow a specific schedule:
First Patient: To be determined according to the clinical schedule.
Second Patient: A Swedish citizen.
Third Patient: A resident of the Kurdistan Region, specifically in the capital, Erbil.
Technical Advantages and Accessibility
Dr. Najar explained that the artificial heart is engineered to overcome traditional issues related to heart failure and strokes. It features a unique operating mechanism designed to avoid the medical complications associated with previous models.
Furthermore, he highlighted the economic impact of the device, noting that the cost will be significantly lower than currently available medical treatments and surgeries for heart patients.
This announcement follows Dr. Najar’s 2021 reveal of the invention, which was the culmination of twenty years of research abroad. He expressed his commitment to bringing this technology to the citizens of Kurdistan, offering to train local doctors on the specialized implantation procedures.
Read the Arabic version: Click here
